Women Healthcare Market Scenario
Market Research Future (MRFR) studied the Women Healthcare Market is anticipated to reach USD 10,403.34 Million by 2030 at 4.10% CAGR during the forecast period 2022-2030.
COVID 19 impact analysis for the women healthcare market is provided with the report. The rise in socio-economic contribution of women across the globe is increasing. Thus, the need for their well-being is crucial. The surge in the women professionals and need for attention towards their health for their work efficacy can support the rise of the women healthcare market in the analysis period. Cases, unique to women, such as menopause and pregnancy among others, requires special care. Thus, the increase in demand for women health solution for different medical situations can add momentum to the market. The spreading awareness about women health solution to the rural corners of the world can also support the expansion of the women healthcare market trends.
The segment assessment of the Women Healthcare Market is done by diagnosis, indications, end users, and treatment.
The indications-based segment of the women healthcare market is infertility, postmenopausal osteoporosis, gynaecologic cancer, polycystic ovary syndrome, reproductive health management and among others. The gynaecologic cancer sub-segments are ovarian, and breast among other types. The postmenopausal osteoporosis can thrive in the years ahead. The reproductive health management segment can rise exponentially.
The diagnosis-based segments of the women healthcare market are diagnostic imaging tests, bone densitometry, ovulation testing, and biopsies among others. The ovulation testing segment can generate considerable revenue for the women healthcare market. The bone densitometry segment can acquire the largest women healthcare market share.
The treatment-based segment of the women healthcare market are surgeries, and therapeutics among others. The therapeutic segment can win high profits for the market.
The end users-based segments of the women healthcare market are gynaecology centers, hospitals clinics, and research institutes among others. High funding in research for effective women healthcare solutions can offer long-term benefit for the market. The introduction of technical innovations in the gynaecology department of different place can support the expansion of the market.
The region-based assessment of the women healthcare market is done across key regions, Europe, North America, APAC, and MEA. In North America, the women healthcare market value can touch USD 21,782.6 Mn by 2023. It is due to their strong economy base and robust exercising of healthcare awareness campaigns undertaken by government to promote women healthcare that the region is expected to witness an exponential rise of the market. In APAC, the cost effectiveness of diagnosis and treatments of several women health issues can support the market expansion in the region. In addition, the awareness about women healthcare solutions is observed to reach the rural corners of the region, which, in turn, can support the expansion of APAC women healthcare market across the review period. In Middle East and African region, the women healthcare market can expand at 5.46% CAGR across 2017-2023. In EU, the women healthcare market can gain momentum as the robust medical technology base of the regions undergoes effective developments.
The women healthcare market players are Pfizer Inc., (U.S.), Allergan plc. (Ireland), Bayer A G (Germany), Amgen (California), Becton Dickinson and Company (U.S.), Merck Co., Inc., (U.S.), Eli Lilly Company (U.S.), and Teva Pharmaceuticals (Israel)
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071